Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 575 of 2228 entries
View as:

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01345669 Org: User:
Start: 10/17/11 End: 09/12/16 Due: 09/12/17

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01397162 Org: User:
Start: 07/21/11 End: 12/23/11 Due: 12/23/12

Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02020577 Org: User:
Start: 12/31/13 End: 04/30/16 Due: 04/30/17

Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259894 Org: User:
Start: 03/31/04 End: - Due: -

Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02489942 Org: User:
Start: 06/12/15 End: 12/04/20 Due: 12/04/21

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Phase: N/A Priority: Normal
NCT ID: NCT02596230 Org: User:
Start: 11/05/15 End: 03/31/19 Due: 03/31/20

Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02198274 Org: User:
Start: 02/29/00 End: - Due: -

Pharmacokinetics of Salmeterol Via HandiHaler® in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02254187 Org: User:
Start: 09/30/05 End: - Due: -

Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02269202 Org: User:
Start: 02/28/02 End: - Due: -

Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01580306 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171520 Org: User:
Start: 05/31/08 End: - Due: -

Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253914 Org: User:
Start: 02/29/04 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02214914 Org: User:
Start: 11/30/06 End: - Due: -

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01159600 Org: User:
Start: 07/31/10 End: - Due: -

Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03187197 Org: User:
Start: 06/20/17 End: 01/11/19 Due: 01/11/20

Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02176499 Org: User:
Start: 02/28/99 End: - Due: -

Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01581931 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

Dose Finding Study of BI 836880 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02674152 Org: User:
Start: 01/05/16 End: 11/04/20 Due: 11/04/21

A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other

Phase: N/A Priority: Normal
NCT ID: NCT03905096 Org: User:
Start: 04/12/19 End: 08/30/19 Due: 08/30/20

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03782792 Org: User:
Start: 01/31/19 End: 01/05/21 Due: 01/05/22

Relative Bioavailability of Dextromethorphan Syrup in Comparison to Dextromethorphan Soft Pastilles in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02191709 Org: User:
Start: 01/31/09 End: - Due: -

This Study in Healthy Men Tests How the Body Takes up BI 1467335

Phase: N/A Priority: Normal
NCT ID: NCT03483506 Org: User:
Start: 04/10/18 End: 06/27/18 Due: 06/27/19

Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02273557 Org: User:
Start: 01/31/03 End: - Due: -

Tiotropium Bromide in Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01179347 Org: User:
Start: 09/30/10 End: - Due: -

Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00975195 Org: User:
Start: 02/28/09 End: 07/31/13 Due: 07/31/14